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N-Oxidation and nitroreduction to yield N-hydroxyarylamines are metabolic steps that are crucial for the genotoxic properties of aromatic amines and
nitroarenes, respectively. N-Hydroxyarylamines can form adducts with DNA, tissue proteins, and the blood proteins albumin and hemoglobin in a
dose-dependent manner. The determination of hemoglobin adducts is a useful tool for biomonitoring exposed populations. We have established the
hemoglobin binding index (HBI) [(mmole compound/mole Hb)/(mmole compound/kg body weight)] of several aromatic amines and nitroarenes in
female Wistar rats. Incorporating values obtained by other researchers in the same rat strain, the logarithm of hemoglobin binding (log HBI) was
plotted against several physicochemical parameters and against calculated electronic descriptors of nitroarenes and arylamines. Most arylamines
and nitroarenes form hydrolyzable (e.g., sulfinamide) adducts with hemoglobin in rats. The amount of hemoglobin binding decreases with the oxidiz-
ability of the arylamines, except for compounds that are substituted with halogens in ortho or meta position. For halogen-substituted arylamines, the
amount of hemoglobin binding is directly proportional to the pKa. Hemoglobin binding of nitroarenes increases with the reducibility of the nitro
group. The structure activity relationships (SAR) for hemoglobin binding of nitroarenes and arylamines are comparable. The SAR found for hemoglo-
bin binding were compared with the SAR found in the literature for mutagenicity, carcinogenicity, and cytotoxicity of arylamines and nitroarenes. In
general, the mutagenicity or carcinogenicity of arylamines increases with their oxidizability. This first set of data suggests that the levels of hemoglo-
bin binding, mutagenicity, and carcinogenicity of arylamines are not determined by the same electronic properties of the compounds, or not by
these properties alone. These results indicate that hemoglobin binding may prove not to be a useful index of the genotoxic potency of arylamines
and nitroarenes. Further work will be performed to investigate whether high hemoglobin binding correlates with high cytotoxic potency of these
compounds. - Environ Health Perspect 102(Suppl 6):61-67 (1994)
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Introduction
Aromatic amines and nitroarenes are very
important intermediates in industrial man-
ufacturing ofdyes, pesticides, and plastics
and are significant environmental pollu-
tants. Ring oxidation, N-glucuronidation,
N-acetylation, and N-oxidation are the
major metabolic pathways ofarylamines in
mammals [review of metabolism in (1,2)].
N-Oxidation is a crucial step in the metab-
olism ofarylamines and aromatic amides to
toxic products. Arylamines are metabolized
in the liver by monooxygenases to highly
reactive N-hydroxyarylamines. Nitroarenes
are reduced by microorganisms in the gut
or by nitroreductases and aldehyde dehy-
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drogenase in hepatocytes to nitrosoarenes
and N-hydroxyarylamines (3). N-Hydroxy-
arylamines can be further metabolized to
N-sulfonyloxyarylamines, N-acetoxyary-
lamines or N-hydroxyarylamine N-glucuro-
nide. These highly reactive intermediates
are responsible for the genotoxic and cyto-
toxic effects (4-7) of this class of com-
pounds. They react with DNA and
proteins (Scheme 1). For 4-aminobiphenyl
(4ABP) (8), it has been shown that the
N02
NO
NH,
Scheme
same metabolite-the N-hydroxyary-
lamine-reacts with DNA of the bladder
and with hemoglobin.
The main goal ofthe present work was
to determine the bioavailability of the N-
hydroxyarylamine for an array of substi-
tuted arylamines and nitroarenes by
measuring the amount of hydrolyzable
adducts formed with rat hemoglobin. The
relationships between hemoglobin binding
of nitroarenes and arylamines and their
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61Table1. Heatofformation ofarylamines andtheircorresponding nitrenium ionscalculated byMNDO, AM1, andPM3.V
MNDO MNDO AM1 AM1 PM3 PM3 E1/2
Amine amine nitrenium amine nitrenium amine nitrenium [V] HBI
4MSA 14.7 226.7 19.6 224.8 21.0 232.8 0.50 3.8
A 21.7 241.5 20.5 246.9 21.3 244.9 0.71 22.0b
4FA -24.7 197.5 -24.6 201.1 -22.3 203.1 0.67 33.0
2CA 15.1 239.6c 13.1 240.5c 14.7 233.6 0.76 0.5
3CA 14.0 240.8c 13.3 245.0c 14.4 241.4c 0.77 12.5
4CA 13.8 239.1 13.1 239.9 14.4 233.8 0.73 569.0b
4BrA 24.1 248.6 24.6 254.8 28.7 254.8 0.74 341.0
41A 32.7 259.3 35.9 267.3 42.5 262.2 0.74 296.0
24DCA 8.0 237.4c 6.3 234.0c 8.1 224.4 0.80d 0.6
26DCA 9.2 238.6 6.3 235.2 8.3 227.4 0.84d
34DCA 9.0 239.9c 7.5 238.7c 9.2 230.7c 0.77 9.0
35DCA 7.1 240.7 6.7 244.0 7.8 238.3 0.84 0.6
2MA 16.2 232.7 13.2 234.0 13.0 232.2 0.70e 4.0b
3MA 14.2 233.1c 13.0 237.7c 12.1 234.0c 0.71e 4.9b
4MA 13.8 231.0 13.0 232.6 12.0 229.7 0.62e 4.3b
2EA 12.3 227.7 8.0 227.7 8.5 227.9 0.67 5.1
3EA 9.4 227.9c 7.3 231.5c 7.4 229.1 0.69 12.7
4EA 9.0 225.5 7.1 226.2 7.3 225.7 0.64 5.8
24DMA 8.4 222.4 5.7 220.6 3.8 217.6 0.59e 2.3b
25DMA 8.6 224.2 5.7 224.8 3.7 221.3 0.65d 7.3
26DMA 11.6 225.1 6.0 222.6 5.0 220.6 0.63 1.1
34DMA 8.9 225.4c 6.1 224.5c 3.4 220.0c 0.59 0.7
35DMA 6.7 225.0 5.6 228.9 2.7 223.5 0.68d 14.0
245TMA 3.3 216.7 -1.2 212.4 -4.6 208.0 0.56e 0.7b
246TMA 3.9 215.3 -1.5 209.5 -4.2 206.3 0.53 0.2
3CNA 52.8 281.6c 52.1 288.Oc 56.3 289.5c 1.5
3TFA -126.7 106.5 -135.7 102.3 -137.1 97.5 0.84 28.4
4TFA -128.2 111.7 -137.1 105.8 -138.0 100.8 0.89 148.0
24DFA -69.6 155.5 -69.3 157.5c -64.8 163.1c 0.74 32.0
3C4FA -29.7 198.8c -29.3 201.2c -27.8 200.3c 0.78 30.7
2C4MA 7.3 229.0c 5.6 226.6c 5.4 219.9 0.68e 1.0
4C2MA 8.3 230.1 f 5.8 227.5f 6.2 221.9f 28.0
5C2MA 8.5 231.5f 6.0 231.7f 6.1 228.4f 0.75e 28.0b
6C2MA 9.9 230.8f 5.9 228.3f 6.4 222.39 0.74e 0.8b
4ABP 46.4 257.3 45.9 259.7 45.3 256.1 0.60e 344.0b
aAIl heat of formation values are expressed as kcal/mole. bThese data were obtained from Neumann (39). cSyn-
conformer. dThese values have been redetermined and revised from Sabbioni (10). 'New experimental data. The
most stable conformer is with the methyl group antito the proton on the nitrogen. gThe most stable conformer is
with the methyl group synto the proton on the nitrogen.
electronic properties were studied. The
structure-activity relationships (SAR) for
hemoglobin binding were compared with
those for their mutagenic and carcinogenic
potency in order to test to which extent
hemoglobin binding may be used as a pre-
dictor for genotoxicity.
Materials and Methods
The experimental details of the work with
nitroarenes have been published elsewhere
(9). The methods for the animal experi-
ments, the isolation ofhemoglobin, and the
quantification of the arylamines bound to
hemoglobin have been published recently
(10). The aromatic amines and nitroarenes
were given to female Wistar rats by gavage,
and the rats were sacrificed 24 hr later. The
hemoglobin was precipitated with ethanol,
hydrolyzed in 0.1 M NaOH in the pres-
ence of recovery standards [e.g., 4-
chloroaniline (4CA), d5-aniline] and
extracted with hexane. The hexane fraction
was analyzed by gas chromatography-mass
spectrometry (GC-MS) with electron
impact ionization in the single ion mode.
Structure identification was based on the
retention time and on the mass spectrum
or the ratio of the main mass fragments.
Arylamines with low hemoglobin binding
were derivatized with pentafluoropropionic
acid anhydride and analyzed by GC-MS.
To establish whether the aromatic amines
recovered from the alkaline hydrolysis were
covalently bound, all samples were
extracted with hexane at neutral pH and
analyzed by GC-MS.
The electronic properties of the ary-
lamines and the nitroarenes were calculated
using the programs Modified Neglect of
Differential Overlap (MNDO), Austin
Model 1 (AM1), and Parametric Method
number 3 (PM3), which are part of
MOPAC 6.0 (Quantum Chemistry
Program Exchange, Indiana University,
Bloomington, IN) (11). The oxidizability
ofarylamines was determined experimen-
tally by HPLC equipped with an electro-
chemical detector (10). The electrode
potential was decreased stepwise (0.05 V)
from 1 to 0.4 V. The peak integrals
obtained (average of two injections) were
plotted against the electrode potential.
The halfwave oxidation potential (E1/2)
was obtained from the resulting hydrody-
namic voltammograms. The values obtained
are listed in Table 1.
Results
Hemoglobin BindingofArylamines
andNitroarenes
Rats were dosed with arylamines or
nitroarenes and sacrificed after 24 hr.
Hemoglobin was hydrolyzed with NaOH.
The released arylamine was extracted in
hexane and analyzed by GC-MS. The
results are summarized in Figures 1A,B,
and 3. The following structure activity rela-
tionships were found:
The highest hemoglobin binding was
obtained with compounds with a halogen
in para position. A chlorine atom in ortho
position reduces the formation ofhemoglo-
bin adducts drastically (1000-fold, for 2CA
compared to 4CA). An additional ortho
chlorine atom, as in 2,6-dichloroaniline
(26DCA) or 2,3,4,5,6-pentachloroaniline
(PCA), abolishes hemoglobin binding
totally. All alkyl substituted amines have
lower hemoglobin binding index (HBI)
[(mmole compound/mole Hb)/(mmole
compound/kg body weight) than aniline.
The HBI of3-ethylaniline (3EA) is higher
than that of 2EA or 4EA. This might be
explained by the fact that the oxidation of
alkyl groups in ortho orpara position to an
amino group is facilitated compared with
that ofalkyl groups in meta position. Two
methyl groups in ortho position, as in 2,6-
dimethylaniline (26DMA) or 2,4,6-
trimethylaniline (246TMA), almost abolish
hemoglobin binding.
In general, lower hydrolyzable hemo-
globin-adduct levels were found in rats that
were given nitroarenes than in rats that
were dosed with an equimolar amount of
the corresponding arylamines [except for
nitrobenzene (NB) and 4-flouronitroben-
zene (4FNB)]. The SAR ofnitroarenes and
arylamines are similar (Figure 2). Highest
hemoglobin binding was found for 4-
chloronitrobenzene (4CNB) or 4-bromoni-
trobenzene (4BrNB). The least binding
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Figure 2. Hemoglobin binding of arylamines and
nitroarenes in rats. The logarithm of the hemoglobin
binding index (log HBI) of the arylamines was plotted
against the log HBI of the corresponding nitroarenes:
log HBI (amines) = 0.86 + 0.65 log HBI (nitroarenes),
r= 0.91. The abbreviations used in the figure are for
the arylamines.
/ nitrenium ion as an intermediate (10,13).
iC2MA a 2C4MA In several studies, nitrenium ions have been
"A *2CA postulated to be the ultimate carcinogens
2.6 3.6 4.6 derived from arylamines (14-20). The
pKa electronic properties of the arylamines and
of the corresponding nitrenium ions were
globin binding of arylamines in rats. calculated with the semiempirical programs
,he hemoglobin binding index (log MNDO, AM1, and PM3. All calculations
3gainst the relative stability of the were performed with the hydrogens of the
trenium ion. Except for 4-amino- * g
Id 4-(trifluoromethyl)-aniline (4TFA), amino group coplanar to the benzene ring,
I-substituted arylamines (19 com- as theinitial of arylamines.
included in the regression analysis: The initial geometry for the calculations of
1.194 AMNDOHF, r= -0.92. The ortho-substituted methyl compounds is
e compounds are mentioned in the critical. Interestingly, equivalent starting
bromoaniline (4BrA), 4-iodoaniline geometries do not always yield the most
iniline (25DMA), 2,6-dimethylaniline stable conformation for all three programs.
nethylaniline (34DMA), and 3,5- The most stable structures are obtained when
5DMA). (B) Hemoglobin binding of the dihedral angle ofCl-C2-CH2-H is 600
The log HBI of aromatic amines for MNDO and AM1 calculations.
a substituent was plotted against However, for PM3 calculations the most
-2.82 + 1.21 pK r=0.81. Hwvr o M acltostems a, stable conformation was obtained starting
with a dihedral angle of00. The energy dif-
ferences between the two conformations
are up to 1.7 kcal/mole for AMI and
h nitrobenzenes with elec- MNDO, and 0.5 kcal/mole for PM3 calcu-
substituents (e.g., 4-methyl- lations. The most stable geometry obtained
2,4-Dichloronitrobenzene for 2EA, 3EA, and 4EA is with the second
10) and 2,3,4,5,6-penta- carbon of the ethyl group out of the ben-
izene (PCNB) (12) do not zene ring plane with a dihedral angle Cl-
Lobin. C2-CH2-CH3 of 900. This change
increases the stability of the conformer by fHemoglobin Bidg approximately 2 kcal/mole for MNDO cal-
ronic Parameters for culations and up to 1. kcal/mole for AM
idNltroaeines and PM3 calculations. However, the most
order to bind to hemoglo- stable structure for the nitrenium ion of
first have to be oxidized to 2EA has a dihedral angle Cl-C2-CH2-
rlamines. In the liver this CH3 of 00. Care must be taken with the
tly catalyzed by cytochrome initial geometry of4-methylmercaptoani-
duct distribution ofthis oxi- line (4MSA) for MNDO calculations. A
s is described best with a dihedral angle C3-C4-S-CH3 of 900
2
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Figure 3. Hemoglobin binding of nitroarenes in rats.
The logarithm of the hemoglobin binding index (log
HBI) was plotted against the energy levels of the low-
est unoccupied molecular orbital (ELUMO) of the
nitroarenes, calculated by the semiempirical method
AM1. All para- and alkyl-substituted nitrobenzenes fit
onto the regression curve: log HBI =-6.26-6.26 ELUMO,
r= -0.85. 3-Chloro-4-fluoronitrobenzene (3C4FNB) and
2,4-difluoronitrobenzene (24DFNB) are outliers. The
HBI values published previously for nitrobenzene (NB)
and 4-nitrobiphenyl (4NBP) were 79 (40) and 30 (41),
respectively. The abbreviations for the compounds are
mentioned in the text, exceptfor 2-methylnitrobenzene
(2MNB)and 3-methylnitrobenzene (3MNB).
increases the stability of this amine by 1.8
kcal/mole. The stability ofthe two possible
rotamers of unsymmetrically substituted
nitrenium ions were compared. In the pre-
vious publication (10) only the anti-con-
former with the single proton on the
nitrogen on the less substituted side was
studied; H-N-C1-C2 = 1800. This was
found not to represent the most stable con-
former in all cases. Therefore, for the pre-
sent study we have calculated stability of
the syn conformer, with the proton on the
nitrogen on the more substituted side with
a dihedral angle H-N-C1-C2 = 00. We
found that compounds with ethyl or
methyl groups in ortho position the anti
conformers are up to 0.9 kcal/mole more
stable. Nitrenium ions with an ortho chloro
group are more stable in the syn conforma-
tion as calculated by MNDO and AM1.
However, with PM3 calculations the anti
conformation is up to 3.6 kcal/mole more
stable. Ths syn conformation is more stable
for most meta-substituted compounds.
The values of the most stable conformers
have been summarized in Table 1. The
enthalpy change AMNDOHF of the
isodesmic reaction (equation 1) yields a
value for the stability ofthe nitrenium ions
relative to that of aniline:AMNDOHF
= MNDOHF(aniline)-MNDOHF(amine)
=[Hf(nitrenium ion of aniline)-Hf(ani-
line)] - [Hf(nitrenium ion of amine) -
Hf(amine)]; Hf=heat of formation calcu-
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Figure 4. Mutagenicity of arylamines in Salmonella
typhimurium TA98. The logarithm of mutagenicity
[revertants per nmole compound] of arylamines was
plotted against the relative stability of the nitrenium
ions: log of mutagenicity, or log MUT = -2.29 + 0.13
AMNDOHF, r= 0.79.
lated by MNDO. For amines in which
nitrenium ions are less stable than the one of
aniline, the enthalpy change is <0 kcal/mole.
The half wave oxidation potentials of
arylamines correlate inversely with the sta-
bility oftheir nitrenium ions, calculated by
MNDO, AM1, and PM3 with r = -0.93,
-0.95, and 0.77, respectively. Arylamines
that form a stable nitrenium ion have a
smaller oxidation potential than arylamines
that form more unstable nitrenium ions
(e.g., 246TMA compared to 4CA). The
oxidizability of the arylamines is directly
proportional to the stability (AMNDOHF)
ofthe corresponding nitrenium ions.
X-Ph-NH+ + PhNH2 -* X-Ph-NH2 + PhNH+ [1]
The log HBI ofall arylamines was plot-
ted against AMNDOHF, AAM1HF, and
APM3HF. The best correlation (r= -0.92)
was found for hemoglobin binding ofpara-
substituted and alkyl-substituted aryla-
mines and the stability of their nitrenium
ions calculated with MNDO (Figure 1A).
Poorer calculations are found when log
HBI was plotted against the stability of
nitrenium ions calculated by AM1, PM3,
and the half wave oxidation potential with
r = -0.80, -0.70, and 0.78, respectively.
For AM 1 and the half wave oxidation
potential the correlations to log HBI
increase to 0.91 and 0.86 if 4MSA is
excluded. The compounds with halogens
in ortho or meta postion, 3-(trifluoro-
methyl)-aniline (3TFA), 3-cyanoaniline
(3CNA), 4-(trifluoromethyl)-aniline
(4TFA), and 4ABP do not fit the curve.
From these SARs found in rats, it appears
that the pharmacokinetics or the metabo-
-1 0 1
log HBI
2 :
Figure 5. Mutagenicity of arylamines in Salmonella
typhimurium TA98 and hemoglobin binding of ary-
lamines in rats. 4-Aminobiphenyl (4ABP) and 2-
chloroaniline (2CA) are not included in the regression
analysis: r=-0.65. HBI, hemoglobin binding index; log
MUT, logarithm of mutagenicity.
lism of 4ABP and 4TFA is different from
that ofthe other para- or alkyl-substituted
arylamines. This difference also might be
the case in humans. Bryant et al. (21)
determined the levels of hemoglobin
adducts ofseveral monocyclic and bicyclic
arylamines in smokers and nonsmokers.
The amount of hemoglobin adducts of
arylamines correlates positively with the
smoker status only for three compounds
(4-ABP, 3-aminobiphenyl, and 2-naphthyl-
amine). The levels ofhemoglobin adducts
ofthe other arylamines were not related to
smoking habits, although these amines are
present in large amounts in cigarette smoke.
Hemoglobin binding ofhalogen-substi-
tuted arylamines can be predicted from the
pKa values (Figure 1B). The pKa values
were taken from the literature (22,23)
except for the pKa of 2,4-difluoroaniline
(24DFA), 3-chloro-4-fluoroaniline (3C4FA),
2-chloro-4-methylaniline (2C4MA), 4-
chloro-2-methylaniline (4C2MA), 5-chloro-
2-methylaniline (5C2MA), and 6-chloro-2-
methylaniline (6C2MA), which were esti-
mated, according to Perrin et al. (24).
Nitroarenes. Nitroarenes have to be
reduced to nitrosoarenes or to N-hydroxy-
arylamine to yield the same sulfinamide
adducts as do arylamines. Therefore, hemo-
globin binding of nitroarenes should
depend on the ease of reduction of the
nitro group. The energy level ofthe lowest
unoccupied molecular orbital (ELUMO) is a
good parameter for predicting the
reducibility of nitroarenes (25,26).
Thirteen nitroarenes were tested for hemo-
globin binding. The logarithm of the
hemoglobin binding index was plotted
against ELUMO (Figure 3). The para- and
alkyl-substituted arylamines fit the regres-
sion curve very well. As in the case of ary-
lamines, compounds with halogens in ortho
or meta position are outliers. Analysis of a
larger group of nitroarenes has been
recently published (9).
Except for two arylamines (2,6-di-
chloroaniline [26DCA] and PCA) and two
nitroarenes (24DCNB and PCNB), all
arylamines and nitroarenes given to female
Wistar rats formed hydrolyzable hemoglo-
bin adducts. Therefore, for most compounds
the potentially genotoxic intermediate-N-
hydroxyarylamine-is bioavailable.
Hemoglobin binding can be predicted with
the electronic properties of the arylamines
and nitroarenes. In a further analysis we
determined ifthe same electronic proper-
ties are predictive for the carcinogenic,
mutagenic, and cytotoxic potency ofthese
arylamines and nitroarenes.
Mutagenicity ofArylamines and
Nitroarenes
Mutagenicity ofArylamines. Are the elec-
tronic properties responsible for high HBI
values the same as those responsible for high
mutagenic and carcinogenic potency? For
several arylamines, it has been shown that
the mutagenic potency increases with the
stability of the corresponding nitrenium
ions (14,15,27). However, several com-
pounds that are not mutagenic should be
mutagenic according to their electronic
properties, for example, aniline, 3CA,
2C4MA, and 4C2MA in Salmonella
typhimurium TA98. Even with the inclu-
sion of additional parameters (partition
coefficients, the energy levels of the
LUMO, and highest occupied molecular
orbital of the arylamines) in a predictive
equation, the mutagenicity of several aryl-
amines is not predicted correctly (28).
In the presentwork, the dataavailable for
the mutagenic potency (28-32) of aryl-
amines, expressed as logarithm ofrevertants
per nmole compound (log MUT), were
plotted against log HBI of the arylamines
and the stability of the corresponding
nitrenium ions. The mutagenic potency is
directly proportional to the oxidizability of
the arylamines (Figure 4) (e.g., 2,4,5-
trimethylaniline [245TMA] is more muta-
genic than 4CA), but inversely proportional
to the amount ofhemoglobin binding in
rats (Figure 5). In addition, several aryl-
amines (e.g., aniline, 3-chloroaniline
[3CA], 2C4MA, and 4C2MA) that are not
mutagenic, bind to hemoglobin.
Mutagenicity ofNitrobenzenes. For a
set of about 20 nitroarenes (most of them
were polyaromatic compounds) Klopman
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Figure 6. Mutagenicity of nitrobenzenes in Salmonella
typhimurium TA100 (34,36) (less data points were
available for the strain TA98 (33). The logarithm of
mutagenicity (log MUT) was plotted against the calcu-
lated energy levels ofthe lowest unoccupied molecular
orbital (ELUMO) of the nitroarenes: r =-0.72
4-Fluoronitrobenzene (4FNB) is not included in the
regression analysis.
et al. (25) and Maynard et al. (26) found
a simple relationship between the elec-
tronic properties of nitroarenes and their
mutagenicity. The mutagenicity increases
with the ease of reduction of the
nitroarenes. With the collection offurther
data, the models for predicting muta-
genicity had to be modified. Additional
factors describing the molecular dimen-
sions, the degree of aromaticity, the
hydrophobicity (33,34and literature cited
therein), or the orientation of the nitro
substituents (35 and literature cited
therein) were included to improve the
predictive value ofthe equations.
The logarithm of the mutagenicity
(34,36) of the nitroarenes which had
been tested for homoglobin binding were
plotted against the reducibility of the
nitro group (ELUMO). The mutagenic
potency and the E LUMO fit on a linear
regression line (Figure 6). The mutagenic-
ity of nitroarenes increases with the
reducibility ofthe nitro group. Except for
NB all compounds tested which bind to
hemoblobin are mutagenic. Conversely,
24DCNB is mutagenic but does not bind
to hemoglobin. Although hemoglobin
binding increases with the reducibility of
the nitro group, the correlation of muta-
genicity with hemoglobin binding is very
poor. This may be a function of insuffi-
cient data points, thus further analyses are
necessary.
Carcinogenicity ofArylamines and
Nitroarenes
Since the late 1970s, there has been a
great deal of interest to elucidate the
chemical properties of aromatic amines
Figure 7. Carcinogenicity of arylamines in rats. Log
1/TD50 [mmolel was plotted against the relative stability
of the nitrenium ions (AMNDOHF): r= 0.63. The TD50
values were obtained from Gold et al. (38).
and nitroarenes that are responsible for
the genotoxicity of this class of
compounds (16-18,37). Much emphasis
has been put on the structural features of
the ultimate carcinogen. Although a
bimolecular mechanism has been
postulated in certain cases, most authors
interpreted the carcinogenic potencies or
the reactions with DNA with a nitrenium
ion as an intermediate (16-18,37). For a
comparison of hemoglobin binding with
the carcinogenicity of arylamines in rats,
the TD50 data compiled by Gold et al.
(38) were used. TD50-values (mmole) of
arylamines tested in rats were found for
only five monocyclic arylamines. Carcino-
genicity increases with the oxidizability of
the arylamines (Figure 7). Carcinogenicity
is inversely proportional to hemoglobin
binding for these compounds (Figure 8).
Only in the case of the bifunctional
arylamines 3,3'-dichlorobenzidine, 4,4'-
methylenedianiline, 4,4'-methylenebis(2-
chloroaniline), 4,4'-oxydianiline, and
benzidine do carcinogenicity and
hemoglobin binding correlate positively
(log(1/TD50 [mmole])=0.7+0.80 log
HBI; r=0.85, data not shown). For the
monocyclic nitroarenes investigated here,
not enough data are available to study the
correlation of carcinogenicity with
hemoglobin binding.
Conclusions
Except for four compounds, it could be
shown that after treating rats with
nitroarenes or arylamines, hydrolyzable
hemoglobin adducts are formed as a result
of the formation of the potentially geno-
toxic intermediate N-hydroxyarylamine.
Hemoglobin adducts are therefore a good
dosimeter to biomonitor people exposed
to a large array of arylamines and nitro-
Figure 8. Carcinogenicity and hemoglobin binding of
arylamines in rats. Log 1/TD50 [mmole] was plotted
against log hemoglobin binding index (log HBI): r=
-0.74. The TD50 values were obtained from Gold et al.
(38).
arenes. The amount ofhemoglobin bind-
ing decreases with the oxidizability of the
arylamines, except for compounds that are
substituted with halogens in ortho or meta
position. For halogen-substituted aryl-
amines, the amount ofhemoglobin bind-
ing is directly proportional to the pK.
The level of hemoglobin binding and
mutagenicity is directly proportional to
the reducibility of the nitroarenes, but
hemoglobin binding and mutagenicity do
not correlate. For arylamines, the elec-
tronic properties that are important for
mutagenicity or carcinogenicity are not
the same as those important for hemoglo-
bin binding. Moreover, the correlation of
carcinogenicity or mutagenicity of aryl-
amines with the electronic properties of
the corresponding nitrenium ions is not as
good as that for hemoglobin binding. For
an equation that better predicts carcino-
genicity, other parameters that are impor-
tant in the process ofcarcinogenesis may
have to be included (e.g., cytotoxicity, Km
and V values of phase I and phase II
max
enzymes, partition coefficient octanol-
water).
Experiments to test for cytotoxic
effects of metabolites of arylamines or
nitroarenes have been performed with
hepatocytes by O'Brien et al. (5) and de
Silva et al. (4). For nitroarenes, it was
shown that cytotoxicity is increased by
electron-withdrawing groups in para posi-
tion to the nitro group.
For arylamines, a new mechanism for
cytotoxic effects of N-hydroxy-2-amino-
fluorene and N-hydroxy-2-aminophenan-
threne has been proposed by Neumann et
al. (6,7). In vitro experiments with mito-
chondria showed that N-hydroxy-2-
aminofluorene or 2-nitrosofluorene
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caused cyanide-resistant oxygen consump-
tion and calcium release. The formation of
superoxide anion radical was demonstrated.
However, several monocyclic arylamines
(nitrosobenzene, 2-nitrosotoluene, 4-
nitrosotoluene, N,N-dimethyl-4-nitro-
sotoluene, and 4-nitrosophenol) did not
cause any oxidative stress; some of them
(nitrosobenzene and 4-nitrosotoluene)
induced calcium release. Further work has
to be performed to see which structural
parameters determine the cytotoxic proper-
ties ofarylamines and their metabolites.
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